SHANGHAI CDYMAX PHARMACEUTICALS CO LTD has a total of 21 patent applications. Its first patent ever was published in 2004. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are LEE PHARMA LTD, SHANGHAI XUANCHUANG BIOLOGICAL SCIENCE & TECH CO LTD and TORCAN CHEMICAL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Organic chemistry methods | |
#4 | Steroids | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Microorganisms | |
#7 | Medical preparations | |
#8 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | An Xiaoxia | 12 |
#2 | Lv Feng | 5 |
#3 | Zhang Liang | 5 |
#4 | Shen Shuxia | 4 |
#5 | Liu Jun | 4 |
#6 | Peng Huan | 4 |
#7 | Zhang Fengjie | 4 |
#8 | Yang Wuli | 3 |
#9 | Huang Chengjun | 3 |
#10 | Bie Pingyan | 3 |
Publication | Filing date | Title |
---|---|---|
CN112110929A | Solid form of Upactinib and preparation method thereof | |
CN112125910A | Alvatinib crystal form and preparation method thereof | |
CN112174982A | Lopitinib crystal form and preparation method thereof | |
CN111777595A | Novel crystal form of cyclohexane carboxamide compound and preparation method thereof | |
CN111825606A | Vat-doxat crystal form and preparation method thereof | |
CN107475344A | A kind of method that vitamin B2 is produced using fermentation of bacillus subtilis | |
CN107475240A | A kind of screening technique of vitamin B2 superior strain | |
WO2014082230A1 | Pyrrolotriazine derivative, preparation method thereof and application thereof in medicine | |
CN103848833A | Pyrrolotriazines derivative, its preparation method and application of pyrrolotriazines derivative on medicine | |
CN103804323A | Jevtana solvate and preparation method and application thereof |